XNAS
LYCA
Oct 26, Last price
28.85USD
Name
Lycia Therapeutics Inc
Chart & performance
P/E
—
P/S
—
EPS
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
Net income
CFO
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory, and allergic diseases. The company was founded in 2019 and is headquartered in South San Francisco, CA.
Key people
Carolyn Bertozzi
Founder
Steve Staben
Chief Scientific Officer · since 2021
Laurent Fischer
Director
Clare Ozawa
Director
William Rieflin
Chairman of the Board · since 2021
Aetna Wun Trombley
President, Chief Executive Officer, Director · since 2021
Tom Woiwode
Director
Valuation
No data to show